Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00756600
Other study ID # 06-07-0320
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date October 23, 2006
Est. completion date June 30, 2018

Study information

Verified date April 2020
Source Boston Children’s Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of the GAS study is to determine whether different types of anesthesia (Regional versus General) given to 720 infants undergoing inguinal hernia repair results in equivalent neurodevelopmental outcomes. The study also aims to describe the incidence of apnea in the post-operative period after both regional and general anesthesia for inguinal hernia repair in infants. This study is important as it will provide the greatest evidence for safety or toxicity of general anesthesia for human infants.


Description:

This is a prospective, observer blind, multi-site, randomized, controlled, equivalence trial. The general anesthesia group will receive sevoflurane (intervention drug) for induction and maintenance of general anesthesia, dose up to 8% inspired for duration of procedure plus bupivacaine local anesthetic blockade (up to 2.5 mg per kg) administered via caudal or ilioinguinal nerve block. The airway can be maintained with a face mask, laryngeal mask or endotracheal tube, with or without neuromuscular blocking agents.

The regional group will have no sedative agent. The regional blockade may be with spinal alone, spinal block with caudal block, spinal with ilioinguinal block or caudal alone. The maximum dose of 2.5 mg per kg of bupivacaine can be used.


Recruitment information / eligibility

Status Completed
Enrollment 643
Est. completion date June 30, 2018
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 60 Weeks
Eligibility Inclusion Criteria:

- Any infant scheduled for unilateral or bilateral inguinal hernia repair (with or without circumcision)

- Any infant whose gestational age is 26 weeks or more (GA = 182 days)

- Any infant whose post-menstrual age is up to 60 weeks (PMA = 426 days)

Exclusion Criteria:

- Any child older than 60 weeks post-menstrual age

- Any child born less than 26 weeks gestation

- Any contraindication to general or spinal/caudal anesthesia (for example: neuromuscular disorder or coagulopathy)

- Pre-operative ventilation immediately prior to surgery

- Congenital heart disease that has required ongoing pharmacotherapy

- Known chromosomal abnormality or any other known acquired or congenital abnormalities (apart from prematurity) which are likely to affect development

- Children where follow-up would be difficult for geographic or social reasons

- Families where English is not the primary language spoken at home

- Known neurological injury such as cystic periventricular leukomalacia (PVL), or grade 3 or 4 intra ventricular hemorrhage (ICH) (+/- post hemorrhage ventricular dilation)

- Previous exposure to volatile anesthesia or benzodiazepines as a neonate or in the third trimester in utero.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Regional Anesthesia
Up to 2.5 mg/kg bupivacaine administered by caudal or subarachnoid routes or both caudal and subarachnoid or subarachnoid and ilioinguinal nerve blockade. Single shot.
General Anesthesia
Sevoflurane for induction and maintenance of general anesthesia, dose up to 8% inspired for duration of procedure plus bupivacaine local anesthetic blockade (up to 2.5 mg/kg) administered via caudal or ilioinguinal nerve block.

Locations

Country Name City State
Australia Casey Hospital Berwick Victoria
Australia Monash Medical Centre Clayton Victoria
Australia Cabrini Hospital Malvern Victoria
Australia Adelaide Women's and Children's Hospital North Adelaide South Australia
Australia Royal Children's Hospital Parkville Victoria
Australia Princess Margaret Hospital Perth Western Australia
Canada Montreal Children's Hospital Montreal Quebec
Canada Centre Hospitalier Universitaire Sainte-Justine Montréal Quebec
Italy Ospedali Riuniti Di Bergamo Bergamo
Italy G. Gaslini Children's Hospital Genoa
Italy 'Vitore Buzzi' Children's Hospital Milano
Netherlands Universitair Medisch Centrum Groningen Groningen
Netherlands Wilhelmina Children's Hospital; University Medical Centre Utrecht Utrecht
New Zealand Starship Children's Health Auckland
United Kingdom Royal Belfast Hospital for Sick Children Belfast
United Kingdom Birmingham Children's Hospital Birmingham
United Kingdom Bristol Royal Hospital for Children Bristol
United Kingdom Royal Hospital for Sick Children Glasgow
United Kingdom Royal Liverpool Children's Hospital Liverpool
United Kingdom Sheffield Children's Hospital Sheffield
United States The Children's Hospital Denver Aurora Colorado
United States Children's Hospital Boston Boston Massachusetts
United States Vermont Children's Hospital at Fletcher Allen Health Care Burlington Vermont
United States Children's Memorial Hospital Chicago Illinois
United States Children's Medical Center of Dallas Dallas Texas
United States The University of Iowa Hospital Iowa City Iowa
United States Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Vanderbilt Children's Hospital Nashville Tennessee
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Seattle Children's Hospital Seattle Washington

Sponsors (5)

Lead Sponsor Collaborator
Boston Children’s Hospital Food and Drug Administration (FDA), Murdoch Childrens Research Institute, Royal Children's Hospital, Royal Hospital for Sick Children

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Italy,  Netherlands,  New Zealand,  United Kingdom, 

References & Publications (1)

Davidson A, McCann ME, Morton N. Anesthesia neurotoxicity in neonates: the need for clinical research. Anesth Analg. 2007 Sep;105(3):881-2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Full Scale IQ Score The primary outcome will be the Wechsler Preschool and Primary Scale of Intelligence-Third Edition (WPPSI-III) full scale IQ score. Verbal, visuo-spatial and processing speed skills are incorporated into the Full Scale IQ score, which is indicative of general intellectual ability.
Minimum score: 45 Maximum score:145 Higher scores are associated with higher IQ scores (better outcome).
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Verbal IQ Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III): Verbal IQ
Minimum possible score:45 Maximum possible score:145
A higher score indicates higher verbal IQ (better outcome).
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years corrected age.
Secondary Performance IQ Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III): Performance IQ
Minimum possible score:45 Maximum possible score:145
A higher score indicates a higher performance IQ (better outcome).
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years corrected age
Secondary Processing Speed Quotient Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III): Processing speed quotient
Minimum possible score:45 Maximum possible score:145
A higher score indicates a better outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years corrected age
Secondary Sentence Repetition Scaled Score Developmental Neuropsychological Assessment second edition (NEPSY-II) sub test: Sentence Repetition scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years chronological age
Secondary Auditory Attention Combined Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Auditory Attention combined scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Statue Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Statue scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Inhibition Combined Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Inhibition combined scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Word Generation Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Word Generation Scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Affect Recognition Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Affect Recognition scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Memory for Names and Memory for Names Delay Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Memory for Names and Memory for Names Delay
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Theory of Mind Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Theory of Mind scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Speeded Naming Combined Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Speeded Naming combined scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Fingertip Tapping Repetitions Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test:Fingertip tapping repetitions scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score is indicative of a better outcome.
At 5 years corrected age
Secondary Fingertip Tapping Sequences Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: fingertip tapping sequences scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Design Copy Process Total Scaled Score Developmental Neuropsychological Assessment Second Edition (NEPSY-II) Sub Test: Design Copy Process Total Scaled Score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years corrected age
Secondary Word Reading Standard Score Weschler Individual Achievement Test (WIAT-II Abbreviated) to assess the academic skills of the child: Word Reading standard score
Minimum possible score: 45 Maximum possible score: 145
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
A higher score indicates a better outcome.
At 5 years chronological age
Secondary Numerical Operations Standard Score Weschler Individual Achievement Test (WIAT-II Abbreviated) to Assess the Academic Skills of the Child: Numerical Operations standard score
Minimum possible score: 45 Maximum possible score: 145
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
A higher score indicates a better outcome.
At 5 years chronological age
Secondary Spelling Standard Score Weschler Individual Achievement Test (WIAT-II Abbreviated) to Assess the Academic Skills of the Child: Spelling standard score
Minimum possible score: 45 Maximum possible score: 145
A higher score indicates a better outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Numbers Total Scaled Score Children's Memory Scale (CMS):Numbers Total scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years chronological age
Secondary Word Lists 1 (Learning) Scaled Score Children's Memory Scale (CMS): Word Lists 1 (learning) scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years chronological age
Secondary Memory and Learning Word Lists II (Delayed) Scaled Score Children's Memory Scale (CMS): Memory and learning Word Lists II (delayed) scaled score
Minimum possible score: 1 Maximum possible score: 19
A higher score indicates a better outcome.
At 5 years chronological age
Secondary The Global Executive Composite (GEC) of the Behaviour Rating of Executive Function Full title: The Global Executive Composite (GEC) of the Behaviour Rating of Executive Function
Preschool Version Parent Form (BRIEF-P) to measure behavioural executive abilities.
Minimum possible score: 40 Maximum possible score: 110
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
A higher score indicates a worse outcome.
At 5 years chronological age
Secondary The Global Adaptive Composite (GAC) of the Adaptive Behavior Assessment System Full title: The Global Adaptive Composite (GAC) of the Adaptive Behavior Assessment System
- 2nd edition (ABAS-II) to measure the child's adaptive behavior.
Minimum possible score: 45 Maximum possible score: 145
A higher score indicates a better outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Total Problems Score Child Behaviour Checklist Caregiver Questionnaire (CBCL): Total Problems Score to measure behavioural problems
Minimum possible score: 40 Maximum possible score: 100
A higher score indicates a worse outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Internalising Problems T Score Child Behaviour Checklist Caregiver Questionnaire (CBCL): CBCL internalising problems T score
Minimum possible score: 40 Maximum possible score: 100
A higher score indicates a worse outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Externalising Problems T Score Child Behaviour Checklist Caregiver Questionnaire (CBCL): externalising problems T score
Minimum possible score: 40 Maximum possible score: 100
A higher score indicates a worse outcome.
Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.
At 5 years chronological age
Secondary Speech or Language Interventions Speech or language issues/interventions. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Psychomotor Interventions Psychomotor issues/interventions. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With Global Developmental Delay Child has global developmental delay. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With Attention Deficit Hyperactivity Disorder Child has been diagnosed with Attention Deficit Hyperactivity Disorder. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With Autism Spectrum Disorder Child has been diagnosis with Autism Spectrum Disorder. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With a Hearing Abnormality Child has a hearing abnormality. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With a Visual Defect in Either Eye Child has a visual defect in either eye. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants With a Hearing Aid Child has a hearing aid. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants Who Are Legally Blind Child is legally blind. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Number of Participants Who Have Cerebral Palsy Child has cerebral palsy. These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Parents' Awareness of Group Allocation Whether or not a parent is aware of which treatment group their child was allocated to. This variable will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Awareness of Group Allocation by Psychologist These variables will be summarised using descriptive statistics by treatment arm only. No treatment effect or confidence intervals will be calculated. At 5 years chronological age
Secondary Awareness of Group Allocation by Pediatrician At 5 years chronological age
See also
  Status Clinical Trial Phase
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT04272320 - The Efficacy of Transversalis Fascia Plane Block in Pediatric Inguinal Hernia Repair N/A
Recruiting NCT03904888 - Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair N/A
Recruiting NCT03856710 - Self Fixating Versus Stapled Mesh for Laparoscopic Inguinal Hernia Repair N/A
Completed NCT02240550 - A Comparative Clinical Study to Evaluate the Effectiveness of ProFlor vs. Lichtenstein for Inguinal Hernia Repair N/A
Completed NCT01679353 - Comparison of Analgesic Effect of Magnesium Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia on Postoperative Pain Control in Pediatric Patients Undergoing Inguinal Hernia Repair N/A
Completed NCT01943760 - Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty Phase 4
Recruiting NCT01450345 - Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain Phase 3
Active, not recruiting NCT00968773 - Rebound Hernia Repair Device Mesh Trial Phase 4
Completed NCT01000116 - Fibrin Glue Versus Tacked Fixation in Groin Hernia Repair (TAPP) N/A
Completed NCT01117337 - Comparing Non-fixation of Mesh to Mesh Fixation in Laparoscopic Inguinal Hernia Repair Phase 4
Terminated NCT00226161 - Chronic Pain After Inguinal Herniorrhaphy N/A
Completed NCT05837013 - Open and Laparoscopic Total Extraperitoneal Repair Under Spinal Anesthesia Versus General Anesthesia N/A
Recruiting NCT05058378 - Correlation Between Spinal Anesthesia and Perfusion Index
Completed NCT01637818 - Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair N/A
Recruiting NCT05879770 - Is the Use of Prolene as Sufficient as the Use of Wire in Shouldice Surgery to Keep the Recurrence Rate Low After One Year?
Completed NCT05159232 - Length of Hospital Stay in Laparoscopic Transabdominal Preperitoneal Vs. Open Mesh Repair in Inguinal Hernia: A Randomised Controlled Trial N/A
Completed NCT05107986 - Laparoscopy in Complicated Groin Hernia
Active, not recruiting NCT04328597 - Portuguese Inguinal Hernia Cohort (PINE) Study
Completed NCT04033055 - Antalgic Efficacy of CycloMesh™ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia. N/A